Tonix Pharmaceuticals offers a unique investment opportunity with its leading candidate, TNX-102 SL, poised to disrupt the $2.1 billion fibromyalgia market. Sporting a robust cash position and no debt, the...
Significant buying activity in SoFi Technologies has raised eyebrows, with recent acquisitions at mid-17 levels contrasting sharply with prior sell-offs at lower prices. This shift suggests a potential inflection point...
In an eye-catching manoeuvre, Jeff Bezos has offloaded more than $5.4 billion in Amazon shares at $217.12 each. This sizable transaction raises questions about its timing, as it occurs amidst...
ImmunityBio emerges as a standout in the immuno-oncology sector with a "Buy" recommendation and a target price of $8.00. The company capitalises on robust revenue growth, recent FDA approvals, and...
Iveda Solutions Inc. (IVDA) offers an intriguing investment opportunity in the AI-driven security sector, with a 40.6% upside potential reflected in the 12-month price target. Despite accelerating revenue growth from...
Goldman Sachs' audacious move to increase its stake in Hims & Hers Health by 45% positions itself as a significant player in the dynamic realm of telehealth. Holding over 8...
Discover how IREN Limited, a former cryptocurrency miner, is pivoting into AI datacentres, aiming for over 500% upside in 24 months. With massive Texas capacity set to exploit insatiable AI...
Rumours are swirling around Zeta Global Holdings as potential buyers eye its AI-driven marketing tech prowess. With a 36% revenue increase in Q1 2025 and the sector ripe for acquisitions,...
Alphabet is stealthily establishing itself as a formidable force in AI infrastructure, leveraging its proprietary Tensor Processing Units (TPUs) to generate 70% of its compute capacity. This move comes as...
A significant investment of roughly 2 million shares in SoFi Technologies for a flagship innovation fund signals renewed confidence in the fintech sector. With a 40% year-on-year revenue growth and...
